ROLE OF PROGESTERONE IN THE TREATMENT OF THREATENED MISCARRIAGE IN FIRST TRIMESTER
Keywords:
Oral progesterone,, vaginal progesterone, threatened miscarriagesAbstract
Objective: To compare the efficacy of oral with vaginal progesterone in the treatment of threatened miscarriage in first
trimester.
Material and Methos: This study was conducted at Department of Obstetrics and Gynaecology, women and children
teaching Hospital Bannu. Duration of the study was one year January 2016 to December 2016. Study design was
randomized controlled trial. In this study 98(49 in each group) patients were observed by women with threatened miscarriage
in their first trimester (up to 12 weeks) and age group 15-45 years were included. All women were subjected
to detailed history and clinical examination. Women were randomly allocated in two groups by lottery method. Women
in Group A was subjected to oral progesterone (10mg twice daily) while women in group B was subjected to vaginal
progesterone (400mg per vaginal for one week). All women were followed till the end of 20th week of pregnancy to
determine the efficacy of either procedure. Efficacy was determined in terms of absence of bleeding per vagina and
pregnancy proceeding beyond 20 weeks of gestation. All information like age, address POG and efficacy were recorded
on pre designed Performa.
Results: Our study shows in oral progesterone group, mean age was 31 years with SD ± 3.88 while in vaginal progesterone
group mean age was 30 years with SD ± 3.12. More over oral progesterone was effective in 90% patients
while vaginal progesterone was effective in 71% patients.
Conclusion: Our study concludes that oral progesterone was more effective than vaginal progesterone in preventing
threatened miscarriages in first trimester.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
